Supplementary Figure from Mutant IDH Inhibits IFNγ–TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma
Meng‐Ju Wu(Broad Institute), Nabeel Bardeesy(Broad Institute), Ramzi Adil(Harvard University), Lei Shi(Broad Institute), Qibiao Wu(Macau University of Science and Technology), Mathias Heikenwälder(University of Tübingen), Ting-Yu Wei(Massachusetts General Hospital), Brandon Nicolay, Russell W. Jenkins(Broad Institute), Amaya Pankaj, Yuanli Zhen(Broad Institute), William Shen(Harvard University), Vikram Deshpande(Beth Israel Deaconess Medical Center), Juan Dubrot(Clinica Universidad de Navarra), Krishna Seshu Tummala, Hongwu Zheng, Lipika Goyal(Stanford Medicine), Cristina R. Ferrone(Cedars-Sinai Medical Center), María García‐Beccaria(German Cancer Research Center), Vindhya Vijay(Broad Institute), Joshua Merritt(Broad Institute), Christine Hudson, Emily Kessler, Rodrigo Saad Berreta(Johns Hopkins University), Kira E. Olander(Broad Institute), Robert T. Manguso(Broad Institute), Meiqi Luo, Sébastien Ronseaux, Yi Sun, Tong Wang(Tulane University), Rahul M. Kohli(University of Pennsylvania), Vajira Weeresekara(Broad Institute), Mirian Fernández-Vaquero(German Cancer Research Center)
Cited by 1
Related Papers
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k